Background/Aims: Janus kinase 3 (JAK3), a kinase mainly expressed in hematopoietic cells, has been shown to down-regulate the Na + /K + ATPase and participate in the regulation of several ion channels and carriers. Channels expressed in thymus and regulating the abundance of T lymphocytes include the voltage gated K + channel KCNE1/KCNQ1. The present study explored whether JAK3 contributes to the regulation of KCNE1/KCNQ1. Methods: cRNA encoding KCNE1/KCNQ1 was injected into Xenopus oocytes with or without additional injection of cRNA encoding wild-type JAK3, constitutively active JAK3 did not accelerate KCNE1/KCNQ1 protein retrieval from the cell membrane. Conclusion: JAK3 contributes to the regulation of membrane KCNE1/KCNQ1 activity, an effect sensitive to JAK3 inhibitor WHI-P154.
Introduction
Janus kinase 3 (JAK3), a kinase mainly expressed in hematopoietic cells [1] [2] [3] is involved in the signalling of hematopoietic cell cytokine receptors [4] [5] [6] [7] [8] , and the regulation of cell proliferation and apoptosis of lymphocytes and tumour cells [9] [10] [11] [12] [13] . An exchange of alanine at 572 by valine yields the gain of function JAK3 [16] . JAK3 is genomically up-regulated [17] and activated [18] upon hypoxia and JAK3 is activated by energy depletion [19] . JAK3 [20] and the related kinase JAK2 [21] are powerful regulators of Na + /K + ATPase and JAK3-deficient mice suffer from impaired renal tubular electrolyte retention and volume depletion [22] . Beyond that JAK3 contributes to the regulation of several carriers [23, 24] and channels [25, 26] ].
Channels expressed in thymus and participating in the regulation of T cell production include KCNE1/KCNQ1 [27] , a voltage sensitive K + channel expressed in a variety of tissues including the heart [28, 29] , skeletal muscle [30] , stria vascularis of the inner ear [31] , renal proximal tubule [32, 33] , gastric parietal cells [33] [34] [35] [36] , intestinal epithelia [32, 34, [36] [37] [38] [39] , and hepatocytes [40] [41] [42] . KCNQ1 channels are involved in cell volume regulation [41] [42] [43] [44] [45] ]. KCNQ1 knockout mice suffer from deafness [46, 47] , impairment of gastric acid secretion [47, 48] , and deranged intestinal electrolyte and substrate transport [33] . KCNQ1 deficiency further impairs cardiac repolarization [49] . In humans, genetic defects of the K + channel subunits KCNE1 or KCNQ1 lead to hearing loss and cardiac arrhythmia [28, 29, 50] . KCNQ1 polymorphisms have further been associated with diabetes [51, 52] .
The present study tested whether JAK3 influences KCNE1/KCNQ1 channel activity. To this end, KCNE1/KCNQ1 was expressed in Xenopus oocytes without or with additional expression of wild type JAK3, constitutively active 
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Ethical Statement
All experiments conform to the 'European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes' (Council of Europe No 123, Strasbourg 1985) and were conducted according to the German law for the welfare of animals. All surgical procedures on the adult Xenopus laevis were reviewed and approved by the respective government authority of the state Baden-Württemberg (Regierungspräsidium) prior to the start of the study (Anzeige für Organentnahme nach 36).
Constructs
Constructs encoding human wild-type KCNE1/KCNQ1 [53, 54] , murine wild-type JAK3, inactive K851A JAK3, and gain of function A568V JAK3 [23] , were used for generation of cRNA as described previously [23, 55] .
Voltage clamp in Xenopus oocytes
Xenopus oocytes were prepared as previously described [56, 57] . 1.5+4.5 ng cRNA encoding KCNE1/ KCNQ1 and/or 10 ng of cRNA encoding wild-type JAK3, active A568V JAK3 or inactive K851A JAK3 were injected on the same day after preparation of the oocytes [58] . The oocytes were maintained at 17°C in ND96-A, a solution containing (in mM): 88.5 NaCl, 2 KCl, 1 MgC1 2 , 1.8 CaC1 2 , 2.5 NaOH, 5 HEPES, 5 sodium pyruvate (C 3 H 3 NaO 3 ). Gentamycin (100 mg/l), Tetracycline (50 mg/l), Ciprofloxacin (1.6 mg/l), and Theophylline (90 mg/l) were added and pH adjusted to 7.4 [59, 60] . Where indicated, brefeldin A (5 µM final concentration) or actinomycin D (50 nM final concentration) were added to the respective solutions [61, 62] . The voltage clamp experiments were performed at room temperature 3 days after the first injection [63, 64] . KCNE1/ KCNQ1 channel currents were elicited every 3 s with 5 s depolarizing pulses up to +80 mV applied from a holding potential of -80 mV. Pulses were applied in 20 mV increments. The data were filtered at 2 kHz and recorded with a Digidata A/D-D/A converter (1322A Axon Instruments) and Clampex 9.2 software for data acquisition and analysis (Axon Instruments) [65] [66] [67] . The control superfusate (ND96-B) contained (in mM): 93.5 NaCl, 2 KCl, 1.8 CaCl 2 , 1 MgCl 2, 2.5 NaOH and 5 HEPES (pH 7.4). The flow rate of the superfusion was approx. 20 ml/min, and a complete exchange of the bath solution was reached within about 10 s [68, 69] .
Results
The present study explored whether Janus activated kinase JAK3 modifies the activity of the voltage gated K + channel KCNE1/KCNQ1. To this end, cRNA encoding KCNE1/KCNQ1 was injected into Xenopus oocytes with or without additional injection of cRNA encoding JAK3 or constitutively active JAK3. An additional series of experiments explored whether the effect of JAK3 could be reversed by the JAK3 inhibitor WHI-P154 (22 µM). To this end, the voltage gated current in oocytes expressing KCNE1/KCNQ1 alone was compared to the voltage gated current in oocytes expressing both, KCNE1/KCNQ1 and A568V JAK3 in the absence and presence of JAK3 inhibitor WHI-P154 (22 µM, added 24 hours prior to the electrophysiological experiments). As illustrated in Fig.3, JAK3 inhibitor WHI-P154 treatment significantly decreased the voltage gated current in oocytes expressing KCNE1/KCNQ1 with A568V JAK3, and virtually abrogated the differences between the voltage gated current in oocytes expressing KCNE1/KCNQ1 alone and oocytes expressing both, KCNE1/KCNQ1 and A568V JAK3. In order to test, whether gene transcription was required for the effect of JAK3, additional experiments were performed in the absence and presence of transcription inhibitor JAK3 on KCNE1/KCNQ1 activity could have resulted from either stimulation of insertion of channel protein into the cell membrane or delayed retrieval of channel protein from the cell membrane. In order to discriminate between those two possibilities, the insertion of new channel protein into the cell membrane was inhibited by incubation of the oocytes with brefeldin A (5 µM). In the presence of brefeldin A, the retrieval of channel protein from the cell membrane is apparent from the decay of voltage gated K + current. As illustrated in Fig. 5 , brefeldin treatment dissipated the differences of voltage gated K + current between oocytes expressing KCNE1/KCNQ1 alone and in oocytes expressing both, KCNE1/KCNQ1 and A568V JAK3. Thus, co-expression of A568V JAK3 did not significantly inhibit the retrieval of channel protein from the cell membrane.
Discussion
The present study reveals a novel effect of JAK3, i.e. the up-regulation of the voltage JAK3 may phosphorylate regulators of KCNE1/KCNQ1 thus indirectly modifying its regulation. JAK3 has previously been shown to down-regulate Na + /K + ATPase activity [20] , which, however, rather decreases K + channel activity [25, 70, 71] . Whatever mechanism, the effect apparently does not require gene expression, as JAK3 is effective even in the presence of transcription inhibitor actinomycin D. Thus, JAK3 apparently regulates KCNE1/KCNQ1 function by mechanisms other than altered gene expression.
The present observations do not allow any predictions on the functional significance of JAK3 sensitive KCNE1/KCNQ1 channel activity. Up-regulation of K + channels may support both apoptosis [72] and cell proliferation [73] [74] [75] . JAK3 is known to stimulate cell proliferation [9] [10] [11] [12] [13] , which may, however, be largely due to mechanisms other than KCNE1/ KCNQ1 activation. Nevertheless, KCNE1/KCNQ1 may participate in the regulation of T cell production [27] . KCNQ1 channels are involved in cell volume regulation and stimulation of KCNE1/KCNQ1 could foster cell shrinkage [41] [42] [43] [44] [45] . Whether JAK3 activity is sensitive to cell volume and whether JAK3 participates in cell volume regulation, remains to be shown, however. Moreover, whether JAK3 participates in any of the multiple KCNE1/KCNQ1 sensitive 
